Sign in
Explore the registryTrack Aficamten's trials

SEQUOIA-HCM

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

Aficamten (5 mg, 10 mg, 15 mg, and 20 mg)CompletedCompletedPhase 3Open NCT05186818 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…